Skip to main content

Advertisement

Table 1 Baseline clinical characterics of the study population

From: Correlation between the functional impairment of bone marrow-derived circulating progenitor cells and the extend of coronary artery disease

  IHD1(n = 40) IHD 2(n = 40) IHD 3(n = 40) P Control Group (n=40)
Age 60 ± 15 60 ± 11 64 ± 10 NS 66 ± 10
male 24 26 25 NS 21
Cardiovascular Risk Factors % (n)
  Hypertension 80 (n = 32) 80 (n = 32) 78 (n = 31) NS -
  Hyperlipidemia 60 (n = 24) 60 (n = 24) 53 (n = 21) NS -
  Smoking 68 (n = 27) 75 (n = 30) 63 (n = 25) NS -
  Positive family history of CAD 40 (16) 40 (n = 16) 35 (n = 14) NS -
  Diabetes 20 (n = 8) 20 (n = 8) 60 (n = 24) p = 0.001 -
   OHA 15 (n = 6) 15 (n = 6) 45 (n = 18) NS -
   Insulin 5 (n = 2) 5 (n = 2) 15 (n = 6) NS -
Total number of CVRFs 4.2 ± 0.8 4.3 ± 0.8 4.4 ± 0.9 NS -
Infarct-related vessel (LAD/LCX/RCA) 19/8/13 20/10/11 20/8/12 NS -
PTCA/Stent at the time of AMI 40/40 40/40 40/40 NS -
Ejection fraction (%) 45 ± 10 43 ± 11 40 ± 10 NS 69 ± 9
Medication (%)      -
Aspirin 100 100 100 NS -
Clopidogrel 100 100 100 NS -
ACE inhibitor or AT II blocker 100 100 100 NS -
Beta-blocker 100 100 100 NS -
Aldosterone Antagonist 25 25 30 NS -
Statin 100 100 100 NS -
  1. Ischemic heart disease (IHD), Oral hypoglycaemic agent (OHA), Coronary artery disease (CAD), Percutaneous transluminal coronary angioplasty (PTCA), Creatine kinase (CK), Left anterior descending coronary artery (LAD), Left circumflex artery (LCX), Right coronary artery (RCA), Coronary artery disease (CAD), Cardiovascular risk factors (CVRFs), Acute myocardial infarction (AMI), None significant (NS).